Samsara Bio Capital, LLC Trillium Therapeutics Inc. Transaction History
Samsara Bio Capital, LLC
- $173 Million
- Q3 2024
About Trillium Therapeutics Inc.
- Ticker TRIL
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 104,995,000
- Market Cap $1.94B